Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 53

    Novartis strikes USD 9.7 billion deal to acquire cholesterol drugmaker The Medicines Co

    Novartis strikes USD 9.7 billion deal to acquire cholesterol drugmaker The Medicines Co

    Medical Dialogues Bureau26 Nov 2019 3:00 PM IST
    Novartis is paying $85 per share in cash, a 24% premium over The Medicines Co's closing price of $68.55 on Friday, to acquire the U.S. biotechnology...
    Indoco Remedies CRO AnaCipher gets Establishment Inspection Report from USFDA

    Indoco Remedies CRO AnaCipher gets Establishment Inspection Report from USFDA

    Farhat Nasim26 Nov 2019 11:30 AM IST
    New Delhi: Drug firm Indoco Remedies Ltd. recently announced the receipt of Establishment Inspection Report (EIR) for its Clinical Research...
    Aurobindo Pharma targets to achieve zero debt in three years sans Novartis deal

    Aurobindo Pharma targets to achieve zero debt in three years sans Novartis deal

    Medical Dialogues Bureau26 Nov 2019 9:30 AM IST
    In September 2018, the USD three billion drug-maker, Aurobindo Pharma said its US subsidiary entered into an agreement to acquire commercial...
    Roche anticipates USFDA nod for SMA drug Risdiplam by early 2020

    Roche anticipates USFDA nod for SMA drug Risdiplam by early 2020

    Medical Dialogues Bureau26 Nov 2019 9:28 AM IST
    Roche, whose drug Risdiplam is seen as a rival for Biogen's Spinraza and Novartis's Zolgensma gene therapy, said the FDA is due to decide by May 24....
    Novartis to buy biotech firm Medicines Co for about USD 7 billion: Report

    Novartis to buy biotech firm Medicines Co for about USD 7 billion: Report

    Medical Dialogues Bureau26 Nov 2019 9:15 AM IST
    The deal, in which Novartis has agreed to pay $85 a share, could be announced this weekend, the Journal reported, citing people familiar with the...
    Cancer drug Alunbrig compared to Xalkori shows longer benefit, says Takeda Pharma

    Cancer drug Alunbrig compared to Xalkori shows longer benefit, says Takeda Pharma

    Medical Dialogues Bureau26 Nov 2019 9:00 AM IST
    Alunbrig, Takeda Pharma's trade name of Brigatinib, reduced the risk of disease progression by 76% in patients whose cancer had spread to the brain...
    Torrent Pharma pulled up by USFDA for significant violations at US plant

    Torrent Pharma pulled up by USFDA for significant violations at US plant

    Medical Dialogues Bureau25 Nov 2019 12:15 PM IST
    In a warning letter issued to Torrent Pharma Inc's CEO Sanjay Gupta, the US Food and Drug Administration (USFDA) said its inspectors found significant...
    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

    Farhat Nasim25 Nov 2019 12:00 PM IST
    The investment of Rs 130 crore includes a significant primary commitment which includes the merger of two Ujala Healthcare hospitals as well as the...
    Unichem Labs gets USFDA nod for generic version of Tenormin tablets

    Unichem Labs gets USFDA nod for generic version of Tenormin tablets

    Farhat Nasim25 Nov 2019 9:45 AM IST
    Unichem Labs said Atenolol tablets USP is a generic version of TENORMIN (Atenolol) Tablets, 25 mg, 50 mg, and 100 mg, of Alvogen Malta Operations...
    India, China spar over legacy of Sowa-Rigpa, medicinal system similar to Ayurveda

    India, China spar over legacy of Sowa-Rigpa, medicinal system similar to Ayurveda

    Medical Dialogues Bureau25 Nov 2019 9:33 AM IST
    “India has approached Unesco seeking the enlisting of the Sowa Rigpa as its ‘intangible cultural heritage’. China has raised an objection to it,” an...
    Lupin launches generic Potassium Chloride for oral solution USP post USFDA nod

    Lupin launches generic Potassium Chloride for oral solution USP post USFDA nod

    Farhat Nasim25 Nov 2019 9:15 AM IST
    Mumbai: Pharma major Lupin Limited (Lupin) recently announced the launch of Potassium Chloride (KCl) for Oral Solution USP, 20 mEq, having received an...
    Tecentriq-Avastin cocktail helps liver cancer patients live longer: Roche

    Tecentriq-Avastin cocktail helps liver cancer patients live longer: Roche

    Medical Dialogues Bureau25 Nov 2019 9:00 AM IST
    Median overall survival for patients with unresectable hepatocellular carcinoma (HCC), or that which cannot be surgically removed, getting Tecentriq...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    Onco.com, dedicated cancer care platform, raises $7 million in Series A funding

    Onco.com, dedicated cancer care platform, raises $7 million in Series A funding

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok